|Transparent Expert Consultation (TEC) considerations and participants|
|TEC summit topic||Areas considered in TEC workshops||Number of attendees||Number of online responders||Backgrounds of individuals attending and responding|
|Ethics||(1) Participation in research; (2) Research ethics committee approval; (3) Informed consent||28||26||ethicists, academics, researchers, members of research ethics committees, clinicians, service providers, commissioners, patients/carers|
|Outcomes||(1) Outcome measure properties; (2) Optimal time points; (3) Validity of proxy data||31||28||academics, researchers, clinicians, commissioners, experts in outcome measurement|
|Mixed methods||(1) Phase I and pre-clinical studies; (2) Phase II and III studies and trials; (3) Implementation studies||33||26||journal editors, academics, researchers, clinicians, experts in health services research/mixed methodology, patients/carers|
|Statistics||(1) Missing data; (2) Attrition; (3) Response shift||20||19||statisticians, researchers, academics, clinicians, patients/carers|
|Health economics||(1) Cost methods and relevance to EoLC; (2) Outcome assessment; (3) Equity issues.||28||34||health economists, service commissioners, researchers, academics, clinicians, patients/carers|
EoLC, end of life care.
Higginson et al.
Higginson et al. BMC Medicine 2013 11:111 doi:10.1186/1741-7015-11-111